Screener
Ocular Therapeutix OCUL Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $8,026 | $4,154 |
| Accrued expenses and other current liabilities | 36,487 | 43,835 |
| Operating lease liabilities | 3,170 | 2,817 |
| Total current liabilities | 47,683 | 50,806 |
| Other liabilities: | ||
| Operating lease liabilities, net of current portion | 4,230 | 2,815 |
| Derivative liability | 12,071 | 13,903 |
| Deferred revenue | 14,000 | 14,000 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's total current liabilities?
- Ocular Therapeutix (OCUL) reported total current liabilities of $47.68M in Q1 2026.
- How has Ocular Therapeutix's total current liabilities changed year-over-year?
- Ocular Therapeutix's total current liabilities increased by 25.7% year-over-year, from $37.93M to $47.68M.
- What is the long-term trend for Ocular Therapeutix's total current liabilities?
- Over 5 years (2020 to 2025), Ocular Therapeutix's total current liabilities has grown at a 13.8% compound annual growth rate (CAGR), from $26.66M to $50.81M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Ocular Therapeutix's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude